Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη της έκφρασης των γλυκοζαμινογλυκανών και πρωτεογλυκανών σε παθήσεις του θυρεοειδούς αδένα

Abstract

dc:description

Glycosaminoglycans are linear acidic polysaccharides, comprising hyaluronic acid, dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate and heparin, which differ in their specific composition. These molecules are encountered in the extracellular matrix and play a major role in the development of tissues’ physiological properties. With the exception of hyaluronic acid, glycosaminoglycans are covalently linked to core proteins to form proteoglycans. Glycosaminoglycans and proteoglycans are involved in important biological events, such as cellular proliferation, adhesion, migration and differentiation. Recently, it has been demonstrated that these molecules participate in neoplastic development and spread. Furthermore, it has been suggested that they may have a role in non-neoplastic, hyperplastic and space occupying lesions. In the field of thyroid diseases, researchers have shown that glycosaminoglycans and proteoglycans may be involved in the pathogenesis not only of neoplastic, but also of hyperplastic and autoimmune lesions. However, there are only a few controlled studies of thyroid expression of each of these molecules in different thyroid pathologies and their results are sometimes discordant. On the other hand, thyroid nodules and goitre are common medical problems and their differential diagnosis may be complicated, leading doctors to dilemmas. Thus, there is a need to establish new diagnostic and prognostic biomarkers, in order to facilitate medical decision making in these cases. Moreover, new therapeutic targets and applications are required in order to treat some patients with thyroid cancer, who do not respond to existing therapies. In this context, the objective of our study was to investigate the differential expression of glycosaminoglycans and proteoglycans in thyroid diseases, as well as the potential diagnostic value of these molecules and their utility in therapeutic applications in different thyroid pathologies. For this purpose, we used tissue specimens dissected from thyroid glands of patients who underwent thyroidectomy for nodular goitre (n=42), thyroiditis Hashimoto (n=l 1), follicular adenoma (n=7) and papillary carcinoma (n=9). Total glycosaminoglycans were isolated from homogenized tissue specimens and they were characterized using glycosaminoglycans-degrading enzymes. In addition, a part of each specimen was elaborated for the extraction of total RNA and the expression of proteoglycans and enzymes metabolizing hyaluronic acid was tested by RT-PCR analysis. We found a statistically significant increase of dermatan sulfate and heparan sulfate in nodular goitre, which was not observed in the other thyroid pathologies examined in our study. As a consequence, this finding could be useful for the differential diagnosis between benign and malignant thyroid nodules. Our results also showed a statistically significant increase of hyaluronic acid in papillary carcinoma, follicular adenoma and thyroiditis Hashimoto, which was associated with: a) increased expression of HAS-2 and HAS-3 in all three diseases; b) decreased expression of both HYAL-1 and HYAL-3 in papillary carcinoma and follicular adenoma and c) decreased expression of HYAL-3 in thyroiditis Hashimoto. Moreover, RT-PCR analysis demonstrated a statistically significant decrease of the expression of syndecan-1 in papillary carcinoma and follicular adenoma and a statistically significant increase of the expression of versican VI in all the thyroid diseases examined in our study. Potentially, these results could be exploited for therapeutic purposes. The above findings indicate that glycosaminoglycans and proteoglycans show distinct features in thyroid diseases which may be helpful in understanding the complex behavior of these diseases, thus eventually leading to novel prognostic, diagnostic and therapeutic strategies.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2010

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Μεμή, Ελένη
  • Memi, Eleni

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/28868

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Μεμή, Ελένη; Memi, Eleni. Μελέτη της έκφρασης των γλυκοζαμινογλυκανών και πρωτεογλυκανών σε παθήσεις του θυρεοειδούς αδένα. Aristotle University Of Thessaloniki (AUTH), 2010. http://hdl.handle.net/10442/hedi/28868